Phase I study of paclitaxel in combination with a multidrug resistance modulator, PSC 833 (Valspodar), in refractory malignancies. (Q54061085)
Jump to navigation
Jump to search
scientific article
Language | Label | Description | Also known as |
---|---|---|---|
English | Phase I study of paclitaxel in combination with a multidrug resistance modulator, PSC 833 (Valspodar), in refractory malignancies. |
scientific article |
Statements
Phase I study of paclitaxel in combination with a multidrug resistance modulator, PSC 833 (Valspodar), in refractory malignancies. (English)
P M Fracasso
P Westervelt
C L Fears
D M Rosen
E G Zuhowski
L A Cazenave
M Litchman
M J Egorin
1 March 2000
18
5
1124-1134